Sonnet BioTherapeutics Holdings, Inc.
SONN · NASDAQ
9/30/2024 | 9/30/2023 | 9/30/2022 | 9/30/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$7,437 | -$18,833 | -$29,722 | -$24,984 |
| Dep. & Amort. | $83 | $76 | $93 | $95 |
| Deferred Tax | $0 | $0 | $0 | -$126 |
| Stock-Based Comp. | $231 | $249 | $876 | $1,375 |
| Change in WC | -$1,869 | -$3,116 | $93 | $1,086 |
| Other Non-Cash | $384 | $282 | $971 | $1 |
| Operating Cash Flow | -$8,608 | -$21,342 | -$27,687 | -$22,552 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$12 | -$443 | -$896 | -$4 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$12 | -$443 | -$896 | -$4 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | -$1 | $0 | -$20 |
| Stock Issued | $3,897 | $21,006 | $1,842 | $42,848 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $2,598 | $1 | $2,173 | $0 |
| Financing Cash Flow | $6,495 | $21,006 | $4,015 | $42,828 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$2,125 | -$779 | -$24,569 | $20,272 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $2,274 | $3,053 | $27,622 | $7,350 |
| End Cash | $149 | $2,274 | $3,053 | $27,622 |
| Free Cash Flow | -$8,608 | -$21,785 | -$28,584 | -$22,556 |